C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 1.490
+0.040 (2.76%)
At close: Feb 13, 2026
C-MER Medical Holdings Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -115.98 | -135.16 | 62 | -21.88 | 21.86 | -6.25 |
Depreciation & Amortization | 202.96 | 213.62 | 220.99 | 224.03 | 148.58 | 113.56 |
Loss (Gain) From Sale of Assets | 1.43 | 1.43 | 0.12 | 0.43 | 5.12 | 0.04 |
Asset Writedown & Restructuring Costs | 199.98 | 199.98 | 2.5 | - | - | 1.36 |
Loss (Gain) From Sale of Investments | -3.44 | -3.44 | 10.74 | 33.22 | -16.71 | -0.04 |
Loss (Gain) on Equity Investments | 0.98 | 0.98 | -3.16 | -37.8 | -10.65 | 0.28 |
Stock-Based Compensation | 0.35 | 0.35 | 0.27 | 1.33 | 4.26 | 5.02 |
Other Operating Activities | -19.62 | 16.24 | 16.72 | -1.75 | -0.63 | -2.9 |
Change in Accounts Receivable | -5.52 | -5.52 | -6.53 | -26.7 | -18.54 | -3.13 |
Change in Inventory | -8.43 | -8.43 | 11.87 | -8.66 | -9.21 | -5.58 |
Change in Accounts Payable | 1.97 | 1.97 | 10.57 | 0.89 | 19.75 | 4.26 |
Change in Unearned Revenue | 4.9 | 4.9 | 15.67 | 30.18 | 1.98 | 0.64 |
Change in Other Net Operating Assets | -3.79 | -3.79 | 19.4 | -28.44 | -1.39 | 2.33 |
Operating Cash Flow | 255.78 | 283.12 | 361.15 | 164.86 | 144.4 | 109.59 |
Operating Cash Flow Growth | -15.08% | -21.61% | 119.06% | 14.17% | 31.76% | -19.88% |
Capital Expenditures | -118.96 | -158.62 | -115.49 | -89.01 | -118.14 | -31.49 |
Sale of Property, Plant & Equipment | 3.17 | 3.26 | 14.52 | 1.26 | 0.01 | 0 |
Cash Acquisitions | -3.96 | -1.4 | - | -94.33 | -236.67 | -155.93 |
Divestitures | - | - | - | - | 5.69 | - |
Sale (Purchase) of Intangibles | -1.01 | -0.77 | -0.37 | -2.22 | -11.09 | -189.32 |
Sale (Purchase) of Real Estate | -99.95 | -99.95 | - | - | - | - |
Investment in Securities | 25.54 | 40.08 | -11.03 | -39.16 | -40 | 218.8 |
Other Investing Activities | 47.72 | 42.68 | -133 | 27.76 | 4.48 | 4.79 |
Investing Cash Flow | -147.46 | -174.72 | -245.37 | -195.7 | -395.73 | -153.15 |
Short-Term Debt Issued | - | 258.27 | 10.78 | 31.26 | 181.11 | - |
Long-Term Debt Issued | - | - | - | 13.8 | 7.49 | - |
Total Debt Issued | 268.07 | 258.27 | 10.78 | 45.06 | 188.6 | - |
Short-Term Debt Repaid | - | -230.84 | -43.28 | -193.24 | -0.66 | - |
Long-Term Debt Repaid | - | -116.94 | -132.09 | -115.44 | -76.1 | -55.48 |
Total Debt Repaid | -365.64 | -347.79 | -175.37 | -308.68 | -76.76 | -55.48 |
Net Debt Issued (Repaid) | -97.57 | -89.52 | -164.59 | -263.62 | 111.84 | -55.48 |
Issuance of Common Stock | - | - | - | 607.66 | 9.25 | 399.36 |
Repurchase of Common Stock | -55.52 | -59.14 | -58.29 | -29.93 | - | - |
Common Dividends Paid | - | - | - | - | -22.97 | -21.52 |
Other Financing Activities | -48.8 | -46.26 | -20 | -20.44 | -13 | -10.35 |
Financing Cash Flow | -201.89 | -194.92 | -242.88 | 293.68 | 85.12 | 312.02 |
Foreign Exchange Rate Adjustments | 8.97 | -3.17 | -4.84 | -4.81 | -1.07 | 3.3 |
Net Cash Flow | -84.6 | -89.68 | -131.94 | 258.04 | -167.28 | 271.76 |
Free Cash Flow | 136.82 | 124.51 | 245.67 | 75.86 | 26.26 | 78.1 |
Free Cash Flow Growth | -6.49% | -49.32% | 223.85% | 188.91% | -66.38% | 521.81% |
Free Cash Flow Margin | 7.07% | 6.51% | 12.77% | 4.38% | 2.36% | 11.16% |
Free Cash Flow Per Share | 0.11 | 0.10 | 0.20 | 0.06 | 0.02 | 0.07 |
Cash Interest Paid | 20.94 | 20.34 | 17.02 | 19.24 | 13 | 10.35 |
Cash Income Tax Paid | 41.84 | 49.2 | 32.55 | 24.94 | 13.72 | 16.95 |
Levered Free Cash Flow | 156.56 | 107.98 | 64.56 | 503.17 | -168.04 | -123.44 |
Unlevered Free Cash Flow | 171.91 | 122.76 | 75.88 | 515.46 | -159.91 | -116.97 |
Change in Working Capital | -10.87 | -10.87 | 50.98 | -32.73 | -7.42 | -1.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.